Evidence map›Paper›PMID 36056186›Full record

ArticleExperimental & molecular medicine2022

Aβ-induced mitochondrial dysfunction in neural progenitors controls KDM5A to influence neuronal differentiation.

Dong Kyu Kim, Hyobin Jeong, Jingi Bae, Moon-Yong Cha, Moonkyung Kang, Dongjin Shin, Shinwon Ha, Seung Jae Hyeon, Hokeun Kim, Kyujin Suh and 8 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Dong Kyu KimDepartment of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea.
Hyobin JeongEuropean Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany.
Jingi BaeDepartment of Chemistry, Center for Proteogenome Research, Korea University, Seoul, Korea.
Moon-Yong ChaLG Chem Life Science R&D Campus, Drug Discovery Center, Seoul, Korea.
Moonkyung KangGraduate School of New Drug Discovery & Development, Chungnam National University, Daejeon, Korea.
Dongjin ShinDepartment of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea.
Shinwon HaDepartment of Brain and Cognitive Sciences, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Korea.
Seung Jae HyeonCenter for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Seoul, Korea.
Hokeun KimDepartment of Chemistry, Center for Proteogenome Research, Korea University, Seoul, Korea.
Kyujin SuhDepartment of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea.
Mi-Sun ChoiDepartment of Predictive Toxicology, Korea Institute of Toxicology (KIT), Daejeon, Korea.
Hoon RyuCenter for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Seoul, Korea.ORCID 0000-0001-6544-3732
Seong-Woon YuDepartment of Brain and Cognitive Sciences, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Korea.
Jong-Il KimDepartment of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea.ORCID 0000-0002-7240-3744
Yeon-Soo KimGraduate School of New Drug Discovery & Development, Chungnam National University, Daejeon, Korea.
Sang-Won LeeDepartment of Chemistry, Center for Proteogenome Research, Korea University, Seoul, Korea. sw_lee@korea.ac.kr.
Daehee HwangDepartment of Biological Sciences, Seoul National University, Seoul, Korea. daehee@snu.ac.kr.ORCID 0000-0003-3608-0885
Inhee Mook-JungDepartment of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea. inhee@snu.ac.kr.ORCID 0000-0001-7085-4085
Seoul National University · KRKorea University · KRChungnam National University · KRDaegu Gyeongbuk Institute of Science and Technology · KRKorea Institute of Brain Science · KRKorea Institute of Toxicology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria in neural progenitors play a crucial role in adult hippocampal neurogenesis by being involved in fate decisions for differentiation. However, the molecular mechanisms by which mitochondria are related to the genetic regulation of neuronal differentiation in neural progenitors are poorly understood. Here, we show that mitochondrial dysfunction induced by amyloid-beta (Aβ) in neural progenitors inhibits neuronal differentiation but has no effect on the neural progenitor stage. In line with the phenotypes shown in Alzheimer's disease (AD) model mice, Aβ-induced mitochondrial damage in neural progenitors results in deficits in adult hippocampal neurogenesis and cognitive function. Based on hippocampal proteome changes after mitochondrial damage in neural progenitors identified through proteomic analysis, we found that lysine demethylase 5A (KDM5A) in neural progenitors epigenetically suppresses differentiation in response to mitochondrial damage. Mitochondrial damage characteristically causes KDM5A degradation in neural progenitors. Since KDM5A also binds to and activates neuronal genes involved in the early stage of differentiation, functional inhibition of KDM5A consequently inhibits adult hippocampal neurogenesis. We suggest that mitochondria in neural progenitors serve as the checkpoint for neuronal differentiation via KDM5A. Our findings not only reveal a cell-type-specific role of mitochondria but also suggest a new role of KDM5A in neural progenitors as a mediator of retrograde signaling from mitochondria to the nucleus, reflecting the mitochondrial status.

Indexed as

Alzheimer DiseaseNeuronsProteomeAmyloid beta-PeptidesAnimalsCell DifferentiationLysineMiceMitochondriaProteomicsRetinoblastoma-Binding Protein 2Amyloid beta-PeptidesKDM5A protein, mouseLysineProteomeRetinoblastoma-Binding Protein 2

Identifiers

PMID36056186
PMCPMC9534996
OpenAlexW4294281109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.